Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-31

Clinical Trial Update: Incidence of Expression of Tumor Antigens in Cancer Tissue From Patients With Pathologically Demonstrated Bladder Cancer

View source ↗

Summary

This completed study assesses how often tumor antigens are expressed in bladder cancer tissue from patients with pathologically confirmed disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Urinary Bladder | Status: COMPLETED